Your browser doesn't support javascript.
loading
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
Dahlman, James E; Barnes, Carmen; Khan, Omar; Thiriot, Aude; Jhunjunwala, Siddharth; Shaw, Taylor E; Xing, Yiping; Sager, Hendrik B; Sahay, Gaurav; Speciner, Lauren; Bader, Andrew; Bogorad, Roman L; Yin, Hao; Racie, Tim; Dong, Yizhou; Jiang, Shan; Seedorf, Danielle; Dave, Apeksha; Sandu, Kamaljeet S; Webber, Matthew J; Novobrantseva, Tatiana; Ruda, Vera M; Lytton-Jean, Abigail K R; Levins, Christopher G; Kalish, Brian; Mudge, Dayna K; Perez, Mario; Abezgauz, Ludmila; Dutta, Partha; Smith, Lynelle; Charisse, Klaus; Kieran, Mark W; Fitzgerald, Kevin; Nahrendorf, Matthias; Danino, Dganit; Tuder, Rubin M; von Andrian, Ulrich H; Akinc, Akin; Schroeder, Avi; Panigrahy, Dipak; Kotelianski, Victor; Langer, Robert; Anderson, Daniel G.
Afiliación
  • Dahlman JE; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Barnes C; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Khan O; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Thiriot A; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA.
  • Jhunjunwala S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Shaw TE; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Xing Y; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA.
  • Sager HB; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Sahay G; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Speciner L; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Bader A; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
  • Bogorad RL; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Yin H; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA.
  • Racie T; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Dong Y; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Jiang S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Seedorf D; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA.
  • Dave A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Sandu KS; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Webber MJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Novobrantseva T; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Ruda VM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Lytton-Jean AKR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Levins CG; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA.
  • Kalish B; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Mudge DK; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Perez M; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Abezgauz L; Vascular Biology Program, Children's Hospital Boston, and Division of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston 02115, USA.
  • Dutta P; Vascular Biology Program, Children's Hospital Boston, and Division of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston 02115, USA.
  • Smith L; Program in Translational Lung Research, Division of Pulmonary Sciences and Critical Care Program, Department of Medicine, University of Colorado School of Medicine, Aurora, USA.
  • Charisse K; Deparment of Biotechnology and Food Engineering, and The Russell Berrie Nanotechnology Institute, Technion Israel Institute of Technology, Haifa 3200, Israel.
  • Kieran MW; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
  • Fitzgerald K; Program in Translational Lung Research, Division of Pulmonary Sciences and Critical Care Program, Department of Medicine, University of Colorado School of Medicine, Aurora, USA.
  • Nahrendorf M; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA.
  • Danino D; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA.
  • Tuder RM; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA.
  • von Andrian UH; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
  • Akinc A; Deparment of Biotechnology and Food Engineering, and The Russell Berrie Nanotechnology Institute, Technion Israel Institute of Technology, Haifa 3200, Israel.
  • Schroeder A; Program in Translational Lung Research, Division of Pulmonary Sciences and Critical Care Program, Department of Medicine, University of Colorado School of Medicine, Aurora, USA.
  • Panigrahy D; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA.
  • Kotelianski V; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA.
  • Langer R; Department of Chemical Engineering, Technion Israel Institute of Technology, Haifa 32000, Israel.
  • Anderson DG; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA.
Nat Nanotechnol ; 9(8): 648-655, 2014 Aug.
Article en En | MEDLINE | ID: mdl-24813696
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polímeros / ARN Interferente Pequeño / Interferencia de ARN / Células Endoteliales / Nanopartículas Límite: Animals / Humans Idioma: En Revista: Nat Nanotechnol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polímeros / ARN Interferente Pequeño / Interferencia de ARN / Células Endoteliales / Nanopartículas Límite: Animals / Humans Idioma: En Revista: Nat Nanotechnol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos